Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, et al. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018;78:1–12. https://doi.org/10.1016/J.JAAD.2017.04.1141.

Article  PubMed  Google Scholar 

Benigno M, Anastassopoulos KP, Mostaghimi A, Udall M, Daniel SR, Cappelleri JC, et al. A large cross-sectional survey study of the prevalence of alopecia areata in the United States. Clin Cosmet Investig Dermatol. 2020;13:259. https://doi.org/10.2147/CCID.S245649.

Article  PubMed  PubMed Central  Google Scholar 

Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, et al. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82:675–82.

Article  CAS  PubMed  Google Scholar 

Mirzoyev SA, Schrum AG, Davis MDP, Torgerson RR. Lifetime incidence risk of alopecia areata estimated at 2.1 percent by Rochester Epidemiology Project, 1990–2009. J Invest Dermatol. 2014;134:1141–2.

Article  CAS  PubMed  Google Scholar 

Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton III LJ. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. In: Mayo Clin Proc. 1995. p. 628–33.

Gandhi K, Shy ME, Ray M, Fridman M, Vaghela S, Mostaghimi A. The association of alopecia areata-related emotional symptoms with work productivity and daily activity among patients with alopecia areata. Dermatol Ther. 2023;13:285–98. https://doi.org/10.1007/s13555-022-00864-1.

Article  Google Scholar 

Mostaghimi A, Gao W, Ray M, Bartolome L, Wang T, Carley C, et al. Trends in prevalence and incidence of alopecia areata, alopecia totalis, and alopecia universalis among adults and children in a US employer-sponsored insured population. JAMA Dermatol. 2023;159:411–8. https://doi.org/10.1001/jamadermatol.2023.0002.

Article  PubMed  PubMed Central  Google Scholar 

Colón EA, Popkin MK, Callies AL, Dessert NJ, Hordinsky MK. Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry. 1991;32:245–51.

Article  PubMed  Google Scholar 

Ghanizadeh A. Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. Int J Dermatol. 2008;47:1118–20.

Article  PubMed  Google Scholar 

Hussain ST, Mostaghimi A, Barr PJ, Brown JR, Joyce C, Huang KP. Utilization of mental health resources and complementary and alternative therapies for alopecia areata: a U.S. Survey. Int J Trichol. 2017;9:160–4. https://doi.org/10.4103/ijt.ijt_53_17.

Article  Google Scholar 

Li SJ, Huang KP, Joyce C, Mostaghimi A. The impact of alopecia areata on sexual quality of life. Int J Trichol. 2018;10:271–4. https://doi.org/10.4103/ijt.ijt_93_18.

Article  Google Scholar 

Mostaghimi A, Xenakis J, Meche A, Smith TW, Gruben D, Sikirica V. Economic burden and healthcare resource use of alopecia areata in an insured population in the USA. Dermatol Ther. 2022;12:1027–40.

Article  Google Scholar 

Huang KP, Mullangi S, Guo Y, Qureshi AA. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States. JAMA Dermatol. 2013;149:789–94. https://doi.org/10.1001/jamadermatol.2013.3049.

Article  PubMed  Google Scholar 

Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015. p. 397–403.

Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011;65:949–56. https://doi.org/10.1016/j.jaad.2010.08.032.

Article  PubMed  Google Scholar 

Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatology Venereol. 2006;20:1055–60. https://doi.org/10.1111/j.1468-3083.2006.01676.x.

Article  CAS  Google Scholar 

Lee S, Lee H, Lee CH, Lee W-S. Comorbidities in alopecia areata: A systematic review and meta-analysis. J Am Acad Dermatol. 2019;80:466-477.e16. https://doi.org/10.1016/j.jaad.2018.07.013.

Article  PubMed  Google Scholar 

Xing L, Dai Z, Jabbari A, Cerise JE, Higgins CA, Gong W, et al. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. Nat Med. 2014;20:1043–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010;466:113–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Betz RC, Petukhova L, Ripke S, Huang H, Menelaou A, Redler S, et al. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 2015;6:5966.

Article  CAS  PubMed  Google Scholar 

McElwee KJ, Hoffmann R. Alopecia areata—animal models. Clin Exp Dermatol. 2002;27:410–7. https://doi.org/10.1046/j.1365-2230.2002.01075.x.

Article  CAS  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:372. https://doi.org/10.1136/BMJ.N71.

Article  Google Scholar 

Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https://doi.org/10.1136/bmj.j4008.

Article  PubMed  PubMed Central  Google Scholar 

Ly S, Kamal K, Manjaly P, Mostaghimi A. Systematic review of comorbidities in alopecia areata. PROSPERO Int Prospect Regist Syst Rev. 2022;CRD4202235.

Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; 2000.

Modesti PA, Reboldi G, Cappuccio FP, Agyemang C, Remuzzi G, Rapi S, et al. Panethnic differences in blood pressure in Europe: a systematic review and meta-analysis. PLoS ONE. 2016;11: e0147601.

Article  PubMed  PubMed Central  Google Scholar 

RStudio Team. RStudio: integrated development for R. Boston: RStudio, PBC; 2020.

Serarslan G, Savaş N, Yenin JZ. Is atopy and autoimmunity more prevalent in patients with alopecia areata? A comparative study. J Eur Acad Dermatol Venereol. 2012;26:720–3. https://doi.org/10.1111/j.1468-3083.2011.04152.x.

Article  CAS  PubMed  Google Scholar 

Wang S, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI. Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA). Am J Med Genet. 1994;51:234–9.

Article  CAS  PubMed  Google Scholar 

Huang KP, Joyce CJ, Topaz M, Guo Y, Mostaghimi A. Cardiovascular risk in patients with alopecia areata (AA): a propensity-matched retrospective analysis. J Am Acad Dermatol. 2016;75:151–4. https://doi.org/10.1016/j.jaad.2016.02.1234.

Article  CAS  PubMed  Google Scholar 

Garzorz N, Alsisi M, Todorova A, Atenhan A, Thomas J, Lauffer F, et al. Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases. J Eur Acad Dermatol Venereol. 2015;29:2429–35.

Article  CAS  PubMed  Google Scholar 

Kridin K, Renert-Yuval Y, Guttman-Yassky E, Cohen AD. Alopecia areata is associated with atopic diathesis: results from a population-based study of 51,561 patients. J Allergy Clin Immunol Pr. 2020;8:1323-1328.e1. https://doi.org/10.1016/j.jaip.2020.01.052.

Article  Google Scholar 

Jagielska D, Redler S, Brockschmidt FF, Herold C, Pasternack SM, Bartels NG, et al. Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance. J Invest Dermatol. 2012;132:2192–7.

Article  CAS  PubMed  Google Scholar 

Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-γ for autoreactive CD8+ T-cell accumulation in the skin. J Invest Dermatol. 2012;132:1869–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertolini M, McElwee K, Gilhar A, Bulfone-Paus S, Paus R. Hair follicle immune privilege and its collapse in alopecia areata. Exp Dermatol. 2020;29:703–25.

Article  CAS  PubMed  Google Scholar 

Paus R, Bulfone-Paus S, Bertolini M. Hair follicle immune privilege revisited: the key to alopecia areata management. In: J Investig Dermatology Symp Proc. 2018. p. S12–7.

Rajabi F, Drake LA, Senna MM, Rezaei N. Alopecia areata: a review of disease pathogenesis. Br J Dermatol. 2018;179:1033–48.

Article  CAS  PubMed  Google Scholar 

Song T, Pavel AB, Wen H-C, Malik K, Estrada Y, Gonzalez J, et al. An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation. J Allergy Clin Immunol. 2018;142:1631–4.

Article  CAS  PubMed  Google Scholar 

Gilhar A. Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J Invest Dermatol. 2005;124:288–9.

Article  PubMed  Google Scholar 

Guttman-Yassky E, Renert-Yuval Y, Bares J, Chima M, Hawkes JE, Gilleaudeau P, et al. Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients. Allergy. 2022;77:897–906.

Article  CAS  PubMed  Google Scholar 

King B, Mostaghimi A, Shimomura Y, Zlotogorski A, Choi G-S, Blume-Peytavi U, et al. Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials. Br J Dermatol. 2022;ljac059.

King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, et al. Two phase 3 trials of baricitinib for alopecia areata. N Engl J Med. 2022;386:1687–99.

Article  CAS  PubMed  Google Scholar 

Betz RC, Pforr J, Flaquer A, Redler S, Hanneken S, Eigelshoven S, et al. Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol. 2007;127:2539–43.

Article